《NCCN食管和食管胃结合部癌临床实践指南(2023 V1版)》更新解读  

Interpretation of the main updates of the NCCN clinical practice guidelines for esophageal and esophagogastric junction cancer(version 1.2023)

作　　者：张萍[1] 苏泉冰 王军[1] ZHANG Ping;SU Quanbing;WANG Jun(The First Ward of Thoracic Radiotherapy,The Fourth Hospital of Hebei Medical University,Shijiazhuang,050000,P.R.China)

机构地区：[1]河北医科大学第四医院胸部放疗一病区,石家庄050000

出　　处：《中国胸心血管外科临床杂志》2023年第7期939-944,共6页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

摘　　要：起源于食管或食管胃交界处的上消化道癌已成为全球面临的主要健康问题。2023年2月28日,美国国立综合癌症网络发布了《食管和食管胃结合部癌临床实践指南(2023 V1版)》。本文将对该版指南较2022 V5版有关治疗和随访的主要更新内容进行解读,以期为我国临床医务工作者开展临床诊治工作提供更好的依据和借鉴。Upper gastrointestinal tract cancers originating in the esophagus or esophagogastric junction constitute a major global health problem.On February 28,2023,National Comprehensive Cancer Network(NCCN)released the clinical practice guidelines for esophageal and esophagogastric junction cancer(version 1.2023).This article will interpret the main updates related to the treatment and follow-up in this version compared to the version 5.2022,in order to provide the Chinese clinicians a better basis and reference for the diagnosis and treatment of the diseases.

关 键 词：食管癌 食管胃结合部癌 NCCN指南 更新解读 

分 类 号：R735[医药卫生—肿瘤]